2003Zhongguo jihua mianyiRequires access

Result of Boosting of Inactivated Hepatitis A Vaccine Healive

Ren Yi-feng

Open publisher page 0 citations

Abstract

With a view to observe the immunogenicity of the Healive ○R inactivated hepatitis A vaccine, 70 HAV-seronegative children in the mountain area villages aged 1-10 years who had received the live attenuated hepatitis A vaccine within one year were selected. All of them administered a booster dose of healive ○R inactivated hepatitis A vaccine. Hepatitis A virus antibody was measured by ELISA assay after one month.The results showed that the anti-HAV positive seroconversion rate was 100% in all children,the GMT was 3,013mIU/ml.The longer the interval between live attenuated hepatitis A vaccine adminustration and the Healive ○R boosting was,the higher the level of anti-HAV and GMT were,it was in accordance with the immune effect of 2-dose of different schedules of Healive ○R inactivated vaccine,but rather lower in anti-HAV and GMT levels.So,Healive ○R inactivated hepatitis A vaccine can be used as booster vaccination to children who had reciered live attenuated hepatitis A vaccine before to induce high anti-HAV and GMT levels.

About this research paper

What this paper is about

With a view to observe the immunogenicity of the Healive ○R inactivated hepatitis A vaccine, 70 HAV-seronegative children in the mountain area villages aged 1-10 years who had received the live attenuated hepatitis A vaccine within one year were selected. All of them administered a booster dose of healive ○R inactivated hepatitis A vaccine. Hepatitis A virus antibody was measured by ELISA assay after one month.The results showed that the anti-HAV positive seroconversion rate was 100% in all children,the GMT was 3,013mIU/ml.The longer the interval between live attenuated hepatitis A vaccine adminustration and the Healive ○R boosting was,the higher the level of anti-HAV and GMT were,it was in accordance with the immune effect of 2-dose of different schedules of Healive ○R inactivated vaccine,but rather lower in anti-HAV and GMT levels.So,Healive ○R inactivated hepatitis A vaccine can be used as booster vaccination to children who had reciered live attenuated hepatitis A vaccine before to induce high anti-HAV and GMT levels.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

With a view to observe the immunogenicity of the Healive ○R inactivated hepatitis A vaccine, 70 HAV-seronegative children in the mountain area villages aged 1-10 years who had received the live attenuated hepatitis A vaccine within one year were selected. All of them administered a booster dose of healive ○R inactivated hepatitis A vaccine. Hepatitis A virus antibody was measured by ELISA assay after one month.The results showed that the anti-HAV positive seroconversion rate was 100% in all children,the GMT was 3,013mIU/ml.The longer the interval between live attenuated hepatitis A vaccine adminustration and the Healive ○R boosting was,the higher the level of anti-HAV and GMT were,it was in accordance with the immune effect of 2-dose of different schedules of Healive ○R inactivated vaccine,but rather lower in anti-HAV and GMT levels.So,Healive ○R inactivated hepatitis A vaccine can be used as booster vaccination to children who had reciered live attenuated hepatitis A vaccine before to induce high anti-HAV and GMT levels.

Key concepts: Hepatitis A vaccine, Hepatitis A, Medicine, Immunogenicity, Seroconversion, Virology, Inactivated vaccine, Booster dose

Related papers

Back to paper searchBrowse research topicsOriginal source
Result of Boosting of Inactivated Hepatitis A Vaccine Healive — Research Paper | ScholarLens